Up-regulation of p21WAF1 expression is mediated by Sp1/Sp3 transcription factors in TGFbeta1-arrested malignant B cells

Medical Science Monitor

Volumn 12, Issue 7, 2006, Pages

  Tvrdík, Daniel ^a   Dundr, Pavel ^a   Povýšil, Ctibor ^a   Pytlík, Robert ^a   Planková, Martina ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cyclin dependent kinase inhibitor; Follicular lymphoma; Sp1 Sp3 transcription factors; Transforming growth factor beta1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSFORMING GROWTH FACTOR BETA1; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PRIMER DNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING AFFINITY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL LINE; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHODGKIN LYMPHOMA; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; B CELL LYMPHOMA; B LYMPHOCYTE; CELL CYCLE; DRUG EFFECT; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

B-LYMPHOCYTES; BASE SEQUENCE; BLOTTING, WESTERN; CELL CYCLE; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; LYMPHOMA, B-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 33745859671     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Niculescu AB, Chen X, Smeets M et al: Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol, 1998; 18: 629-43
2. Grana X, Reddy EP: Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases cdks, growth suppressor genes and cyclin-dependent kinase inhibitors CKIs. Oncogene, 1995; 11: 211-19
3. Dulic V, Stein GH, Far DF, Reed SI: Nuclear accumulation of p21 (Cip1/Waf1) at the onset of mitosis: A role at the G2/M transition. Mol Cell Biol, 1998; 18: 629-43
4. Golubnitschaja O, Moenkemann H, Trog DB et al: Activation of genes inducing cell-cycle arrest and of increased DNA repair in the hearts of rats with early streptozotocin-induced diabetes mellitus. Med Sci Monit, 2006; 12(2): BR68-74
5. Welcker M, Lucas J, Strauss M, Bartek J: p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells. Cancer Res, 1998; 22: 5053-56
6. LaBaer J, Garrett MD, Stevenson LF et al: New functional activities for the p21 family of CDK inhibitors. Genes Dev, 1997; 7: 847-62
7. Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature, 2000; 408: 307-10
8. Jiang H, Lin J, Su ZZ et al: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21WAF1/CIP1 expression in the absence of p53. Oncogene, 1994; 9: 3397-406
9. Liu M, Iavarone A, Freedman LP: Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem, 1996; 271: 31723-28
10. Yan GZ, Ziff EB: Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J Neurosci, 1997; 17: 6122-32
11. Erhardt JA, Pittman RN: Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment. J Biol Chem, 1998; 273: 23517-23
12. Gartel AL Tyner AL: Transcriptional regulation of the p21 (WAF1/CIP1) gene. Exp Cell Res, 1999; 246: 280-89
13. Bouwman P, Philipsen S: Regulation of the activity of Sp1-related transcription factors, Mol Cell Endocrinol, 2002; 195: 27-38
14. WAF1/Cip1 gene promoter. Biochemistry, 2002; 41: 12771-84
15. Gartel AJ, Goufman E, Najmabadi F, Tyner AL: Sp1 and Sp3 activate p21 (WAF1/CIP) gene transcription in Caco-2 colon adenocarcinoma cell line. Oncogene, 2000; 19: 5182-88
16. Biggs JR, Kudlow JE, Kraft AS: The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J Biol Chem, 1996; 271: 901-6
17. Somasundaram K, Zhang H, Zeng YX et al: Arrest of the cell cycle by the tumoursuppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature, 1997; 389: 187-90
18. Datto MB, Yu Y, Wang XF: Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem, 1995; 270: 28623-28
19. Prowse DM, Bolgan L, Molnar A, Dotto GP: Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation. J Biol Chem, 1997; 272: 1308-14
20. Nakano K, Mizuno T, Sowa Y et al: Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem, 1997; 272: 22199-206
21. Sowa Y, Orita T, Minamikawa S et al: Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem Biophys Res Commun, 1997; 241: 142-50
22. Nozell S, Chen X: p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family. Oncogene, 2002; 21: 1285-94
23. Gorospe M, Wang X, Holbrook NJ: p53-dependent elevation of p21Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system. Mol Cell Biol, 1998; 18: 1400-7
24. Rozga J: Hepatocyte proliferation in health and in liver failure. Med Sci Monit, 2002; 8(2): RA32-38
25. Bouchard C, Fridman WH, Cautes C: Effects of TGF-beta1 on cell cycle regulatory proteins in LPS-stimulated normal mouse B lymphocytes. J Immunol, 1997; 159: 4155-64
26. Kluin-Nelemans HC, Limpers J, Meerabux J et al: A new non-Hodgkin's B-cell line DoHH2 with a chromosomal translocation t(14;18)(q32;q21). Leukemia, 1991; 5: 221-24
27. nd edition, John Wiley, New York, 1992
28. Tvrdík D, Svatošová J, Dundr P, Povýš il C: Molecular Diagnosis of Synovial Sarcoma: Detection of SYT-SSX1/2 Fusion Transcripts by RT-PCR in Paraffin-Embedded Tissue. Med Sci Monit, 2005; 11(3): MT1-7
29. Ko TC, Sheng HM, Reisman D et al: Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene, 1995; 10: 177-84
30. Slingerland JM, Hengs L, Pan CH et al: A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol, 1994; 14: 3683-94
31. Grau AM, Zhang L, Wang W et al: Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res, 1997; 57: 3929-34
32. Kim JW, Kim HS, Kim IK et al: Transforming growth factor-beta 1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma. Gynecol Oncol, 1998; 69: 230-36
33. Chaouchi N, Arvanitakis L, Auffredou MT et al: Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene, 1995; 11: 1615-22
34. Arvanitakis L, Yaseen N, Sharma S: Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J Immunol, 1995; 55: 1047-56
35. WAF1 in growth-arrested lymphoma cells. J Struct Biol, 2002; 140: 49-56
36. Jeffrey PD, Tong I, Pavletich NP: Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev, 2000; 14: 3115-25
37. Kaldis P, Russo AA, Chou H et al: Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities. Mol Biol Cell, 1998; 9: 2545-60
38. Bagui TK, Jackson RJ, Agrawal D, Pledger WJ: Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1). Mol Cell Biol, 2000; 20: 8748-57
39. Saha P, Eichbaum Q, Silberman ED et al: p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol Cell Biol, 1997; 17: 4338-45
40. Waf1/Cip1/Sdi1 C-terminal domain bound to Cdk4. J Biomolec Str, 2001; 19: 419-27
41. Suske G: The Sp-family of transcription factors. Gene, 1999; 238: 291-300
42. Hagen G, Muller S, Beato M, Suske G: Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res, 1992; 20: 5519-25
43. Gill G, Pascal E, Tseng ZH, Tjian R: A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc Natl Acad Sci USA, 1994; 91: 192-96
44. Lee JS, Galvin KM, Shi Y: Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1. Proc Natl Acad Sci USA, 1993; 90: 6145-49
45. Udvadia AJ, Templeton DJ, Horowitz JM: Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc Natl Acad Sci USA, 1995; 92: 3953-57
46. Lin SY, Black AR, Kostic D et al: Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol Cell Biol, 1996; 16: 1668-75
47. Hirano F, Tanaka H, Hirano Y et al: Functional interference of Sp1 and NF-kappaB through the same DNA binding site. Mol Cell Biol, 1998; 18: 1266-74
48. WAF1/Cip1. J Cell Physiol, 2005; 204: 260-72
49. WAF1/CIP1 by transforming growth factor. J Biol Chem, 1999; 274: 35381-87
50. Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites. Oncogene, 1999; 18: 6252-61
51. Waf1/Cip1 regulation by transforming growth factor-β. J Biol Chem, 2000; 275: 29244-56
52. Moustakas A, Pardali K, Gaal A, Heldin CH: Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol Lett, 2002; 82: 85-91